Home > Healthcare > Medical Devices > Therapeutic Devices > Lung Stent Market

Lung Stent Market Trends

Report ID: GMI4873
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Lung Stent Market Trends

The increasing prevalence of respiratory disorders along with the rising rate of surgical intervention is propelling the demand for minimally invasive treatment, further incorporating the demand for lung stents. The implementation of these stents offers better patient compliance as while aiding in maintaining optimal levels of vessel patency. Lung stent placement is among the preferred choice in the therapeutic treatment of malignant airway lesions due to their satisfactory clinical outcomes. Reduced surgical complications, rapid recovery, shorter stays in the hospitals, and effective management of post-surgical pain are other factors accelerating the demand for minimally invasive treatments.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Lung stent industry size was more than USD 165 million in 2022 and is estimated to grow at over 11.5% CAGR from 2023 to 2032 driven by the increasing prevalence of COPD and post-tuberculosis stenosis globally.

The tracheal product segment held 69% of the lung stents market revenue share in 2022 and is expected to grow at robust pace through 2032 owing to the decreased risk of surgical complications.

North America lung stent industry generated over USD 72.9 million in 2022 and is anticipated to grow at robust pace through 2032 driven by the rise in hospitalizations for respiratory disorders.

Some of the key lung stent firms include Merit Medical Systems, Inc., Boston Scientific Corporation, Micro-Tech (Nanjing) Co., Ltd., Hood Laboratories, Cook Group, Taewoong Medical Co Ltd, and Novatech SA, among others.